Mark A. Velleca

Insider Reports History

Location
Research Triangle Park, NC
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Velleca:

Company Role Class Num Shares Value Price $ Report Date Ownership
G1 Therapeutics, Inc. Director Common Stock 116,000 $341,307 $2.94 08 Aug 2023 Direct
Black Diamond Therapeutics, Inc. PRESIDENT & CEO, Director Common Stock 121,522 $303,805 $2.50 30 Jan 2025 Direct
Black Diamond Therapeutics, Inc. PRESIDENT & CEO, Director Stock Option (Right to Buy) 600,000 21 Jan 2026 Direct
G1 Therapeutics, Inc. Director Stock Option (Right to Buy) 242,286 08 Aug 2023 Direct

Insider Reports Filed by Mark A. Velleca

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BDTX Black Diamond Therapeutics, Inc. 21 Jan 2026 1 $0 4 PRESIDENT & CEO, Director 23 Jan 2026, 16:05
BDTX Black Diamond Therapeutics, Inc. 30 Jan 2025 2 $0 4 PRESIDENT & CEO, Director 31 Jan 2025, 16:37
BDTX Black Diamond Therapeutics, Inc. 14 Feb 2024 1 $0 4 PRESIDENT & CEO, Director 15 Feb 2024, 17:35
BDTX Black Diamond Therapeutics, Inc. 15 Sep 2023 2 +$18,749 4 PRESIDENT & CEO, Director 18 Sep 2023, 17:26
/report/000156218023006271-velleca-mark-a-2023-08-08 G1 Therapeutics, Inc. 08 Aug 2023 6 -$96,818 4 Director 10 Aug 2023, 16:11
BDTX Black Diamond Therapeutics, Inc. 16 Jun 2023 1 +$18,751 4 Director 16 Jun 2023, 17:41
BDTX Black Diamond Therapeutics, Inc. 16 May 2023 1 $0 4 Director 17 May 2023, 21:09
BDTX Black Diamond Therapeutics, Inc. 16 Mar 2023 1 +$18,751 4 Director 20 Mar 2023, 16:33
BDTX Black Diamond Therapeutics, Inc. 16 Dec 2022 1 +$12,636 4 Director 19 Dec 2022, 20:16
/report/000156218022007293-velleca-mark-a-2022-10-18 G1 Therapeutics, Inc. 18 Oct 2022 3 -$169,640 4 Director 20 Oct 2022, 16:05
/report/000156218022006791-velleca-mark-a-2022-09-20 G1 Therapeutics, Inc. 20 Sep 2022 3 -$262,244 4 Director 22 Sep 2022, 16:40
BDTX Black Diamond Therapeutics, Inc. 16 Sep 2022 1 +$11,250 4 Director 19 Sep 2022, 17:09
/report/000156218022006214-velleca-mark-a-2022-08-16 G1 Therapeutics, Inc. 16 Aug 2022 3 -$979,704 4 Director 18 Aug 2022, 16:06
BDTX Black Diamond Therapeutics, Inc. 17 Jun 2022 1 +$11,250 4 Director 17 Jun 2022, 16:27
BDTX Black Diamond Therapeutics, Inc. 10 Jun 2022 1 $0 4 Director 13 Jun 2022, 19:08
BDTX Black Diamond Therapeutics, Inc. 18 Mar 2022 1 +$8,749 4 Director 18 Mar 2022, 16:05
/report/000156218022001223-velleca-mark-a-2022-02-07 G1 Therapeutics, Inc. 07 Feb 2022 2 +$5,850 4 Director 08 Feb 2022, 15:05
/report/000156218021006964-velleca-mark-a-2021-11-09 G1 Therapeutics, Inc. 09 Nov 2021 2 +$15,600 4 Director 10 Nov 2021, 15:05
BDTX Black Diamond Therapeutics, Inc. 09 Aug 2021 1 $0 4 Director 11 Aug 2021, 16:58
BDTX Black Diamond Therapeutics, Inc. 09 Aug 2021 0 $0 3 Director 11 Aug 2021, 16:56
/report/000156218021004949-velleca-mark-a-2021-07-13 G1 Therapeutics, Inc. 13 Jul 2021 9 -$558,558 4 Director 15 Jul 2021, 16:01
/report/000156218021004348-velleca-mark-a-2021-06-15 G1 Therapeutics, Inc. 15 Jun 2021 9 -$647,321 4 Director 17 Jun 2021, 16:05
/report/000156218021003737-velleca-mark-a-2021-05-25 G1 Therapeutics, Inc. 25 May 2021 2 +$7,800 4 Director 25 May 2021, 18:29
/report/000156218021003460-velleca-mark-a-2021-05-11 G1 Therapeutics, Inc. 11 May 2021 9 -$585,401 4 Director 13 May 2021, 16:43